North Ridge Wealth Advisors Inc. Has $1.20 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

North Ridge Wealth Advisors Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,274 shares of the healthcare conglomerate’s stock after selling 56 shares during the quarter. UnitedHealth Group accounts for approximately 1.0% of North Ridge Wealth Advisors Inc.’s investment portfolio, making the stock its 20th biggest position. North Ridge Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $1,197,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Moneta Group Investment Advisors LLC boosted its holdings in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth $5,210,004,000. Arrowstreet Capital Limited Partnership raised its position in UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Barclays PLC raised its position in UnitedHealth Group by 143.4% during the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after purchasing an additional 2,058,829 shares during the last quarter. Finally, Morgan Stanley raised its position in UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $494.70 on Friday. The company has a market capitalization of $456.08 billion, a P/E ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70. The business has a 50-day simple moving average of $503.10 and a two-hundred day simple moving average of $518.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.34 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is presently 31.54%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. HSBC reaffirmed a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.